Advances in Applied Science Research Open Access

  • ISSN: 0976-8610
  • Journal h-index: 57
  • Journal CiteScore: 93.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Perspective - (2022) Volume 13, Issue 12

Nanoparticle Properties for Drug Delivery and Cell Barrier
Martin Vinck*
 
Department of Biochemistry, Roskilde University, Denmark
 
*Correspondence: Martin Vinck, Department of Biochemistry, Roskilde University, Denmark, Email:

Received: 30-Nov-2022, Manuscript No. AASRFC-23-15469; Editor assigned: 02-Dec-2022, Pre QC No. AASRFC-23-15469 (PQ); Reviewed: 16-Dec-2022, QC No. AASRFC-23-15469; Revised: 21-Dec-2022, Manuscript No. AASRFC-23-15469 (R); Published: 28-Dec-2022, DOI: 10.36648/0976-8610.13.12.105

INTRODUCTION

Nanoparticles (NPs) are an interesting possibility for addressing therapeutic delivery problems. Knowing which NP traits to use to overcome these issues may result in superior in vivo responses. This study used a cell barrier model to examine NPs produced from five different materials in three distinct sizes and concentrations. The permeability of nanoparticles through a cell barrier was examined, as well as their impact on cell barrier integrity and viability. These NPs’ properties were compared to cell responses in water (conventional) vs. medium (realistic). It was discovered that the best predictor of cell responsiveness for all cellular activities was NP characteristics tested in medium. Notably, ZnO NPs reduced cell viability in all three cell types tested. We also discovered that NP zeta potential is strongly related to NP permeability and NP-induced cell viability alterations. NPs with a physiological zeta potential of 12 mV easily pass through the cell barrier without generating major changes in cell viability.

Description

In the present era of pharmaceutical administration, solubility and permeability are key limiting parameters for bioavailability and efficacy. Despite efforts to improve drug solubility, these treatments’ penetration across biological barriers to their site of action remains problematic. To reach the site of action, drugs must pass through a number of biological barriers, including, but not limited to, the gastrointestinal barrier, epithelial barriers of blood vessels, and so on. Transcellular transport is preferred by large, hydrophobic medicines, while paracellular transport is preferred by small, hydrophilic compounds.

Nanoparticle (NP) drug carriers are being investigated as a potential method for bypassing biological barriers in drug delivery. Many other types of NPs, such as inorganic NPs, polymeric NPs, and liposomes, are now being investigated for a variety of drug delivery applications. Metals and other inorganic nanoparticles offer potential in drug delivery.

The ability to predict nanoparticle interactions with cells during the design stages could be immensely valuable to the advancement of nanomedicine. A biological barrier model was used to assess the interaction of NPs at three different concentrations manufactured from five different materials with varying sizes and surface characteristics. In general, we discovered that Fe2O3 NPs performed the best, with excellent penetration across the cell barrier model and only small alterations in cell viability as a result. These nanoparticles have the potential to be employed as drug carriers.

Because nanostructures remain in the blood’s circulatory system for an extended period of time, amalgamated medications can be released at the precise dose. They produce less plasma fluctuations and have fewer harmful consequences. Nanoparticles have been discovered to be effective in gathering information at all phases of clinical practises due to their application in several innovative tests for treating and diagnosing diseases. Because a variety of proteins can cling to the surface of these nanoparticles, their surface features are responsible for their fundamental advantages. For example, gold nanoparticles are used as biomarkers and tumour labels in a variety of biomolecule detection assays.

Conclusion

We were unable to conduct a pooled analysis to compare deep learning models with radiologists in our study due to a lack of studies providing radiologists’ sensitivity. More articles comparing the two groups are needed, particularly for tiny, difficult- to-detect lesions, according to the researchers.

Citation: Vinck M (2022) Nanoparticle Properties for Drug Delivery and Cell Barrier. Adv Appl Sci Res. 13:105.

Copyright: © 2022 Vinck M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.